MD SB819 | 2019 | Regular Session
Status
Spectrum: Bipartisan Bill
Status: Introduced on February 4 2019 - 25% progression, died in committee
Action: 2019-02-18 - Hearing 3/06 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 4 2019 - 25% progression, died in committee
Action: 2019-02-18 - Hearing 3/06 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring the Secretary of Health, by a certain date each year, to identify a certain number of certain prescription drugs on which the State spends a certain amount of money; requiring the Secretary to require a certain pharmaceutical manufacturer to report certain cost changes and expenditures during a certain period of time; requiring the Secretary, by a certain date each year, to publish a report on the Maryland Department of Health's website based on the information the Secretary receives under certain provisions of the Act; etc.
Title
Health Insurance - Pharmaceutical Manufacturers - Transparency and Reporting
Sponsors
History
Date | Chamber | Action |
---|---|---|
2019-02-18 | Senate | Hearing 3/06 at 1:00 p.m. |
2019-02-18 | Senate | Hearing canceled |
2019-02-11 | Senate | Hearing 3/13 at 1:00 p.m. |
2019-02-04 | Senate | First Reading Finance |
Subjects
Disclosure
Fees
Health Insurance
Health Maintenance Organizations
Health, Department of
Insurance - Health
internet
Pharmacists and Pharmacies
Prices
Fees
Health Insurance
Health Maintenance Organizations
Health, Department of
Insurance - Health
internet
Pharmacists and Pharmacies
Prices